China Pioneer Pharma Holdings Ltd is a renowned pharmaceutical company dedicated to delivering value through its commitment to innovation, quality, and customer satisfaction. The company's core values revolve around integrity, professionalism, and continuous improvement. With a customer-centric approach, China Pioneer Pharma Holdings Ltd strives to provide top-notch healthcare solutions, leveraging state-of-the-art technology and extensive expertise. By consistently adhering to its corporate philosophy of "Advancing Health for All," the company aims to make a positive impact on society by addressing medical needs and improving accessibility to advanced medical treatments. China Pioneer Pharma Holdings Ltd sets the industry standard by fostering a culture of excellence and pushing boundaries in pharmaceutical research, development, and manufacturing.

China Pioneer Pharma Holdings Ltd is primarily present in various countries and regions. The company's presence extends to different parts of the world, including but not limited to China, Hong Kong, and Singapore. It has strategically established a strong presence in these regions to expand its business operations and tap into the growing demand for pharmaceutical products. China Pioneer Pharma Holdings Ltd's global presence enables it to cater to a wide customer base and leverage its expertise in the pharmaceutical industry to deliver innovative solutions and drive sustainable growth.

China Pioneer Pharma Holdings Ltd has achieved several significant milestones. The company has successfully expanded its business operations and established a strong presence in the pharmaceutical industry. It has actively pursued strategic partnerships and collaborations to enhance its product offerings and market reach. Moreover, China Pioneer Pharma Holdings Ltd has consistently achieved impressive financial growth, demonstrating its strong performance and profitability. The company's focus on innovation, quality, and customer satisfaction has contributed to its reputation as a leading player in the industry. With its continuous drive for excellence, China Pioneer Pharma Holdings Ltd is poised to achieve even greater success in the future.

China Pioneer Pharma Holdings Ltd is a reputable pharmaceutical company with a rich history and background. Established in [year], the company has emerged as a key player in the pharmaceutical industry. China Pioneer Pharma Holdings Ltd specializes in the research, development, production, and distribution of high-quality medicines and healthcare products. With a strong focus on innovation, the company has consistently introduced novel and effective pharmaceutical solutions to the market. Over the years, China Pioneer Pharma Holdings Ltd has built a solid reputation for its commitment to quality, reliability, and customer satisfaction. With its extensive expertise and consistent growth, the company continues to create a positive impact on the pharmaceutical landscape, driving improvements in healthcare across the globe.

The main competitors of China Pioneer Pharma Holdings Ltd in the market include Beijing Tiantan Biological Products Co., Ltd., Yunnan Baiyao Group Co., Ltd., and Zhejiang Hisun Pharmaceutical Co., Ltd.

China Pioneer Pharma Holdings Ltd is primarily active in the pharmaceutical industry.

The business model of China Pioneer Pharma Holdings Ltd revolves around pharmaceutical distribution and retailing. As a leading company in China's pharmaceutical supply chain, China Pioneer Pharma focuses on sourcing and distributing drugs, medical devices, and healthcare products. The company operates a comprehensive network of distribution centers, logistics facilities, and retail pharmacies across China, providing a wide range of products to hospitals, clinics, and consumers. By leveraging its strong distribution capabilities and industry expertise, China Pioneer Pharma aims to enhance accessibility to quality healthcare products and contribute to the overall development of China's healthcare industry.

P/E santykio šiuo metu Shanghai Pioneer Holding apskaičiuoti negalima.

KUV šiuo metu negali būti apskaičiuotas Shanghai Pioneer Holding.

AlleAktien kokybės įvertis Shanghai Pioneer Holding yra 5/10.

Pajamos šiuo metu negali būti apskaičiuotos Shanghai Pioneer Holding.

Pelnas šiuo metu negali būti apskaičiuotas Shanghai Pioneer Holding.

China Pioneer Pharma Holdings Ltd is a Hong Kong-based company specializing in the research, development, manufacturing, and marketing of pharmaceuticals, medical devices, and health products. The company operates in various sectors that encompass a wide range of product categories. The company produces a variety of medications covering a wide range of diseases and health issues, including cancer, cardiovascular diseases, diabetes, and mental illnesses. In addition, it offers medical devices for diagnostics, therapy, and rehabilitation. Furthermore, the company produces a variety of health products, such as dietary supplements, vitamins, minerals, personal hygiene products, and body care products. It has a wide distribution network, utilizing direct channels with hospitals, doctors, resellers, pharmacies, as well as online channels. The company also collaborates with other pharmaceutical companies for marketing and distribution of medical products. It has a strong research and development pipeline and collaborates with research institutions and universities to develop new technologies and products. The company is committed to improving the quality of life by developing innovative technologies and products. With a strong focus on quality, brand building, and customer service, the company aims to maintain its leading position in the industry.

Shanghai Pioneer Holding moka dividendą 0,08 CNY, kuris yra paskirstytas per išmokas per metus.

Dividenda šiuo metu negali būti apskaičiuota Shanghai Pioneer Holding arba įmonė dividendų nemoka.

Shanghai Pioneer Holding ISIN yra KYG2162L1068.

Shanghai Pioneer Holding akcijų simbolis yra 1345.HK.

Per paskutinius 12 mėnesių Shanghai Pioneer Holding išmokėjo dividendą, kurios dydis siekė 0,07 CNY . Tai atitinka maždaug 3,85 % dividendų grąžą. Artimiausiems 12 mėnesiams Shanghai Pioneer Holding tikėtina išmokės dividendus, kurie sudarys 0,07 CNY.

Shanghai Pioneer Holding šiuo metu yra 3,85 % dydžio dividendų grąža.

Shanghai Pioneer Holding moka dividendus kas ketvirtį. Jie išmokami birželis, lapkritis, birželis, lapkritis mėnesiais.

Shanghai Pioneer Holding per paskutiniuosius 4 metus kiekvienais metais mokėjo dividendus.

Artimiausiems 12 mėnesiams tikimasi dividendų, kurių dydis yra 0,07 CNY. Tai atitinka 3,85 % dividendų grąžos procentą.

Shanghai Pioneer Holding priskiriamas sektoriui "Sveikata".

Norėdamas gauti paskutinį Shanghai Pioneer Holding dividendą nuo 2024-11-15, kurio dydis yra 0,048 CNY, turėjai turėti akciją savo depozite prieš ex-dieną, kuri buvo 2024-10-30.

Paskutinės dividendų išmokėjimas įvyko 2024-11-15.

2023 metais Shanghai Pioneer Holding išmokėjo 0,082 CNY dividendų.

Shanghai Pioneer Holding dividendai yra mokami CNY.